Class ITerminatedD-0228-2017
Drug recall · December 28, 2016
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I recall
Why: Non-Sterility; microbial contamination identified as Bacillus circulans
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502
- Lots / codes
lot #07172016@1, exp 1/13/2017
- Quantity
- 12 vials
- Company
- Town and Country Compounding and Consultation Services, Ridgewood, NJ
- Distribution
- MA, NY, NJ & FL; Canada
- Initiated
- August 1, 2016 · Voluntary: Firm initiated
- Classified
- December 22, 2016
- Reported
- December 28, 2016
- Ended
- October 8, 2019
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.